Table 1 Anti-seizure medications used by eligible patients in relation to seizure control during pregnancy
ASMs at conception | Seizures during the entire pregnancy | |
|---|---|---|
Yes (n = 52) | No (n = 73) | |
Valproate monotherapy | 2 (3.8%) | 4 (5.5%) |
Levetiracetam monotherapy | 13 (25%) | 32 (43.8%) |
Carbamazepine monotherapy | 9 (17.3%) | 14 (19.2%) |
Lamotrigine monotherapy | 1 (1.9%) | 0 (0.0%) |
Oxcarbazepine monotherapy | 3 (5.8%) | 0 (0.0%) |
Polytherapy | 24 (46.2%) | 23 (31.5%) |